Non-small cell lung cancer (nsclc) Clinical Trials
Conditions / Non-small cell lung cancer (nsclc)
Delta Trials records 3 clinical trials for Non-small cell lung cancer (nsclc) in its publicly accessible dataset. From the full dataset, 2 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 57 study locations around the world. An additional 1 trial are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
3
Total Trials
2
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
57
Study Locations
Browse by location (57 total)
- Houston, United States 2 trialsAll trials in Houston, United States
- Los Angeles, United States 2 trialsAll trials in Los Angeles, United States
- Boston, United States 2 trialsAll trials in Boston, United States
- Rochester, United States 2 trialsAll trials in Rochester, United States
- Lyon, France 1 trialAll trials in Lyon, France
- Beijing, China 1 trialAll trials in Beijing, China
- Jacksonville, United States 1 trialAll trials in Jacksonville, United States
- Bologna, Italy 1 trialAll trials in Bologna, Italy
- Celebration, United States 1 trialAll trials in Celebration, United States
- Washington D.c., United States 1 trialAll trials in Washington D.c., United States
- Nantong, China 1 trialAll trials in Nantong, China
- Linyi, China 1 trialAll trials in Linyi, China
- Toulouse, France 1 trialAll trials in Toulouse, France
- Chengdu, China 1 trialAll trials in Chengdu, China
- Boise, United States 1 trialAll trials in Boise, United States
- Detroit, United States 1 trialAll trials in Detroit, United States
- Ulm, Germany 1 trialAll trials in Ulm, Germany
- Wuhan, China 1 trialAll trials in Wuhan, China
- Toronto, Canada 1 trialAll trials in Toronto, Canada
- Nanchang, China 1 trialAll trials in Nanchang, China